Unlock instant, AI-driven research and patent intelligence for your innovation.

Optically pure dipeptide derivative, preparation method and medical application thereof

A pharmaceutical and compound technology, applied in the field of dipeptidyl peptidase inhibitors and treatment of diabetes, can solve problems such as poor chemical stability

Inactive Publication Date: 2014-08-27
CHINA PHARM UNIV
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most of these molecules have the characteristics of poor chemical stability.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Optically pure dipeptide derivative, preparation method and medical application thereof
  • Optically pure dipeptide derivative, preparation method and medical application thereof
  • Optically pure dipeptide derivative, preparation method and medical application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0114] (R)-N-(1,1-Dimethylethoxycarbonyl)-2-(3-hydroxyadamantyl-1-yl)glycine

[0115] (1) (R)-2-adamantyl-2-((S)-1-phenyl-2-hydroxyethylamino)acetonitrile

[0116] Suspend 50g of adamantane formaldehyde in 500mL of water and cool to 0°C. 31.7g of sodium bisulfite and 14.9g of sodium cyanide were added to the suspension in turn. Finally, 41.7g of S-phenylglycinol was dissolved in 180mL of methanol, and slowly dropped into the reaction system. After stirring at room temperature for 2 hours, it was heated to reflux for 16 hours, and then cooled to room temperature. Dilute with 350mL ethyl acetate, separate layers, and extract the aqueous phase with ethyl acetate again. The organic phases were combined, washed twice with saturated brine, and dried over anhydrous sodium sulfate to obtain a brown oil. The crude product could be recrystallized from methanol and water to obtain 51 g (61%) of white crystals. 1 H-NMR (300MHz, CDCl 3 )1.56-1.78(m, 13H), 2.03(m, 3H), 2.87(s, 1H), 3.5...

Embodiment 2

[0126] (R)-2-adamantyl-2-((R)-1-phenyl-2-hydroxyethylamino)acetonitrile

[0127] Since the d.e. value of the stereoselective strecker reaction is about 90%, the generated product mainly contains the target product (S)-2-adamantyl-2-((R)-1-phenyl-2-hydroxyethylamino) Acetonitrile and (R)-2-adamantyl-2-((R)-1-phenyl-2-hydroxyethylamino)acetonitrile, it is necessary to separate the optical isomer (R)-2-adamantyl -2-((R)-1-phenyl-2-hydroxyethylamino)acetonitrile, as a reference substance, so as to establish a method for monitoring the d.e. value of the reaction. The separation method adopts column chromatography, and the eluent ratio is petroleum ether / ethyl acetate 20 / 1, which is too pure. 1 H-NMR (300MHz, CDCl 3 )1.66-1.78(m, 13H), 2.06(m, 3H), 3.20(s, 1H), 3.70(m, 1H), 3.77(m, 1H), 3.93(m, 1H), 7.35-7.38(m ,5H); 13 C-NMR (300MHz, CDCl 3 )28.2, 29.8, 36.7, 38.8, 60.1, 63.6, 65.6, 119.2, 127.4, 128.3, 128.9, 140.1; ESI-MSm / z: 311.1 [M+H] + .

Embodiment 3

[0129] (R)-2-((2S)-2-Amino-2-(3-hydroxyadamantyl-1-yl)acetamido)phenylpropanoic acid

[0130] (1) (R)-2-((2S)-2-(1,1-dimethylethoxycarbonylamino)-2-(3-hydroxyadamantyl-1-yl)acetamido)phenylpropanoid methyl ester

[0131] 1g (S)-N-(1,1-dimethylethoxycarbonyl)-2-(3-hydroxyadamantyl-1-yl)glycine and 1.24g N-hydroxybenzotriazole (HOBt ) was dissolved in 35 mL of dichloromethane, cooled to 0°C, 948 mg of 1,3-dicyclohexylcarbodiimide (DCC) was dissolved in 35 mL of dichloromethane, and slowly dropped into the reaction flask. After the dropwise addition, 729 mg of D-phenylalanine methyl ester hydrochloride was added in batches, and then 1.27 mL of triethylamine was added, and the reaction was carried out at room temperature for 24 hours. The solvent was evaporated, and 200 mL of ether was added to the reaction flask to dissolve the product, and the insoluble solid was removed by filtration. The filtrate was collected, washed twice with 1 mol / L sodium hydroxide, 1 mol / L hydrochlori...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a new optically pure dipeptide derivative shown as the compound in general formula (I) or its pharmaceutically acceptable salts, a preparation method and application of the compound as a drug, especially application as a dipeptidyl peptidase IV (DPPIV) inhibitor for treatment of diabetes. Specifically, R1, R2 and R3 are defined as the specification. (formula I).

Description

technical field [0001] The present invention relates to novel optically pure dipeptide derivatives, a process for their preparation and the use of the compounds as medicines, especially dipeptidyl peptidase (DPPIV) inhibitors for the treatment of diabetes. Background technique [0002] Diabetes mellitus is an endocrine and metabolic disease characterized by hyperglycemia that seriously endangers health. It is the third largest non-communicable chronic disease in the world. According to the latest data from the International Diabetes Federation (IDF), there were approximately 239 million diabetics in the world in 2007. It is expected to reach 438 million in 2030. At present, the number of diabetic patients in my country ranks second in the world, and it is expected to reach 59.31 million in 2025. In 2006, diabetes ranked the tenth cause of inpatients in China and the sixth cause of death among urban residents. Therefore, the prevention and treatment of diabetes is a major ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/05A61K31/277A61K31/16C07K5/065C07C255/44C07C253/30C07C229/28C07C227/18C07C271/22C07C269/06A61P3/10A61P3/04A61P3/06A61P9/00
Inventor 孙宏斌董吉喆柳军
Owner CHINA PHARM UNIV